Oncology Learning Network Live Daily
ASCO 2026 Morning Livestream, Day 2
04/28/2026
Thank you for visiting. On-demand content is coming soon.
This session highlights clinically relevant data in early breast cancer, focusing on durability and de-escalation strategies. Experts also examine PARP-based intensification in prostate cancer and ongoing debates around escalation, with an emphasis on patient selection, toxicity, and real-world applicability.
© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.
